Research Article

Significant Increase in Cytotoxic T Lymphocytes and Natural Killer Cells by Triphala: A Clinical Phase I Study

Table 1

The percentage of lymphocyte subpopulations before and after Triphala ingestion ( ).

Cell typesThe percentage of lymphocyte (mean ± SD)
D0D7D14D21D28

CD3+CD45+60.56 ± 14.5748.78 ± 12.45a55.61 ± 13.2253.82 ± 11.43a53.06 ± 10.98a
CD3+CD4+CD45+25.79 ± 9.4218.65 ± 6.02a21.49 ± 6.72a20.46 ± 6.29a19.97 ± 5.60a
CD3+CD8+CD45+26.62 ± 10.2122.77 ± 10.33a25.56 ± 11.0825.28 ± 10.9124.73 ± 10.02
CD3CD8+CD45+9.48 ± 5.2012.76 ± 5.2211.94 ± 6.14b12.10 ± 5.5010.67 ± 4.20
CD19+CD45+9.94 ± 4.4611.41 ± 5.7311.27 ± 5.5811.56 ± 5.0b12.55 ± 5.56b
CD16+56+CD45+30.64 ± 15.3441.16 ± 12.81b38.72 ± 12.97b38.12 ± 10.62b36.88 ± 9.84
CD25+CD4+CD45+1.88 ± 1.300.96 ± 0.54a2.12 ± 2.071.31 ± 0.88a0.69 ± 0.32a
CD69+CD45+3.27 ± 1.503.06 ± 1.623.19 ± 1.742.60 ± 1.19a1.52 ± 0.69a

aSignificant decreased, P < 0.05; bSignificant increased, P < 0.05.